News items related to: News
-
MMA position on DTG after trials identify potential safety concerns for use at the time of conception
Doultegravir (DTG) is a highly effective, tolerable antiretroviral medicine with a high barrier to resistance; in 2015, WHO recommended it...
-
Five years after the Indian Supreme Court’s Novartis verdict
Five years after this landmark decision, the impact is being felt around the world. India’s decision is frequently held up...
-
Patent backlogs fuel efforts to extend pharma patent terms in Thailand and Brazil, AIDS activists say
Excessive patenting in the multinational pharmaceutical sector, along with a huge backlog, works in Big Pharma’s favour. Civil society is...
-
Groups target EU-Mercosur FTA to advance access to health in trade deals
AIDS activists, health activists and civil society organizations in Brazil and Argentina are pushing back against the negative effects of...
-
Collective efforts by civil society groups bar the way to Hepatitis C patents
Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position...
-
Truvada case shows civil society’s success with pre-grant opposition
The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to...
-
Thailand: Evergreened patents cause unwarranted high drug prices
Transnational drug manufacturers’ tactics of obtaining unmerited patent applications have unnecessarily raised healthcare costs and impeded the growth of domestic...
-
Civil society key in TRIPS flexibility implementation
Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...
-
Launched: I-MAK’s Special Edition Roadmap on Tenofovir Alafenamide Fumarate (TAF)
A critical analysis of TAF, as part of a Roadmap series, aims to help the international community assess the best...
-
Gilead’s patent application on sofosbuvir rejected in Brazil
Rejected! That was the decision issued by Brazil’s National Institute of Industrial Property (INPI) over one of Gilead’s patent applications...
-
Ukraine eyes patent law reform after civil society push on medicines access
Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups...
-
ADVOCATES PUBLISH COMMENTARY ON EXPANDING TREATMENT ACCESS FOR VIRAL HEPATITIS C
On 2 April 2018, an in-depth commentary on practical actions that can help increase access to HCV direct-action antivirals (DAAs)...